AU6589200A - Extended release formulation of etodolac - Google Patents

Extended release formulation of etodolac

Info

Publication number: AU6589200A
Authority: AU; Australia
Prior art keywords: etodolac; release formulation; extended release; formulation; extended
Prior art date: 1999-09-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU65892/00A

Inventor

Rajeev S. Raghuvanshi

Ashok Rampal

Himadri Sen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ranbaxy Laboratories Ltd

Original Assignee

Ranbaxy Laboratories Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-10

Filing date

2000-08-30

Publication date

2001-04-17

1999-09-10 Priority claimed from IN1210DE1999 external-priority patent/IN190974B/en

2000-08-30 Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd

2001-04-17 Publication of AU6589200A publication Critical patent/AU6589200A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AU65892/00A 1999-09-10 2000-08-30 Extended release formulation of etodolac Abandoned AU6589200A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
IN1210/DEL/99		1999-09-10
IN1210DE1999 IN190974B (en)	1999-09-10	1999-09-10
US09648949		2000-08-25
US09/648,949 US6586005B1 (en)	1999-09-10	2000-08-25	Extended release formulation of etodolac
PCT/IB2000/001208 WO2001019349A2 (en)	1999-09-10	2000-08-30	Extended release formulation of etodolac

Publications (1)

Publication Number	Publication Date
AU6589200A true AU6589200A (en)	2001-04-17

Family

ID=26324703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU65892/00A Abandoned AU6589200A (en)	1999-09-10	2000-08-30	Extended release formulation of etodolac

Country Status (3)

Country	Link
CN (1)	CN1227001C (en)
AU (1)	AU6589200A (en)
WO (1)	WO2001019349A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0206505D0 (en) *	2002-03-19	2002-05-01	Euro Celtique Sa	Pharmaceutical combination
AU2003214551A1 (en) *	2002-04-11	2003-10-20	Ranbaxy Laboratories Limited	Controlled release pharmaceutical compositions of carbidopa and levodopa
BRPI0611618A2 (en) *	2005-06-22	2011-05-31	Takeda Pharmaceutical	tablet
WO2007123021A1 (en)	2006-04-12	2007-11-01	Nippon Soda Co., Ltd.	Method for producing extended release tablet
CN101259113B (en) *	2008-04-21	2013-02-13	沈阳药科大学	Etodolac osmotic pump type controlled-release preparation and preparation thereof
TR200908308A1 (en)	2010-01-18	2011-08-22	Turgut İlaçlari A.Ş.	Sustained-release tablet formulation containing etodolac
CN102485215B (en) *	2010-12-03	2013-05-15	沈阳药科大学	Etodolac time-release pellet preparation and preparation method thereof
GB201420306D0 (en)	2014-11-14	2014-12-31	Bio Images Drug Delivery Ltd	Compositions
CN106727390A (en) *	2015-11-19	2017-05-31	哈尔滨圣吉药业股份有限公司	A kind of etodolac sustained released tablets and preparation method thereof
CN114699380A (en) *	2021-12-27	2022-07-05	南京联智医药科技有限公司	Etodolac tablet and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2178686A1 (en) *	1995-06-13	1996-12-14	Leslie G. Humber	Oral formulations of s(+)-etodolac
US6251430B1 (en) *	1998-02-04	2001-06-26	Guohua Zhang	Water insoluble polymer based sustained release formulation
US6106862A (en) *	1998-08-13	2000-08-22	Andrx Corporation	Once daily analgesic tablet

2000
- 2000-08-30 WO PCT/IB2000/001208 patent/WO2001019349A2/en active Application Filing
- 2000-08-30 AU AU65892/00A patent/AU6589200A/en not_active Abandoned
- 2000-08-30 CN CNB008143196A patent/CN1227001C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2001019349A3 (en)	2001-08-09
CN1402631A (en)	2003-03-12
CN1227001C (en)	2005-11-16
WO2001019349A2 (en)	2001-03-22

Publication	Publication Date	Title
AU3867400A (en)	2000-10-09	Methods of using bioelastomers
AUPP970099A0 (en)	1999-05-06	Concrete formulation
AU6314900A (en)	2001-02-13	Biarylurea derivatives
HUP0203680A3 (en)	2005-01-28	Controlled release hydrocodone formulations
AU6714700A (en)	2001-03-26	Cyclopropylindole derivatives
AU1278701A (en)	2001-05-14	Novel compounds
AU4458700A (en)	2000-11-02	Uses of phenylglycine derivatives
AU2557500A (en)	2000-08-29	Methods of making compounds
AU5429000A (en)	2001-01-31	Novel bicyclonucleoside derivatives
AU4213299A (en)	2000-12-18	Controlled release of substances
AU6510400A (en)	2001-03-05	Slow release microspheres
AU6564600A (en)	2001-03-26	Copolymers of acryloyloxyalkylamino compounds
AU3670000A (en)	2000-10-23	Novel thiazolobenzimidazole derivatives
AU7952800A (en)	2001-04-30	2-alkoxybenzene derivatives
AU2001232948A1 (en)	2001-08-07	Controlled release of drugs
AU6589200A (en)	2001-04-17	Extended release formulation of etodolac
AU6690300A (en)	2001-04-17	Copolymers of acryloylaminoalkyl compounds
AU2982000A (en)	2000-09-21	Preparation of 9-hydrocarbyl-9-phosphabicyclononanes
AU5433699A (en)	2001-03-13	Spacing of tiles
AU3775500A (en)	2000-10-16	Setting of gemstones
AU2829700A (en)	2000-09-28	Processes for the preparation of alpha-aminoketones
AU1601801A (en)	2001-05-30	Methods of preparing crna
AU4081300A (en)	2001-04-30	Centroid integration
AU7711800A (en)	2001-04-24	Novel uses of 2-bromopalmitate
AUPQ044699A0 (en)	1999-06-10	Article of footwear

Legal Events

Date	Code	Title	Description
2002-05-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase